Department of Gynecology and Obstetrics, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
Department of Infection Monitor, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
Biomed Pharmacother. 2020 Sep;129:110339. doi: 10.1016/j.biopha.2020.110339. Epub 2020 Jun 17.
Ovarian cancer endangers the life of women worldwide. Plenty of lncRNAs have been found modulating the progression of ovarian cancer. Meanwhile, lncRNA DSCR8 (Down syndrome critical region 8) has been reported as an oncogene in hepatocellular carcinoma. In this study, we aimed to search the function of DSCR8 in ovarian cancer. qRT-PCR analysis assessed the expression of DSCR8 in ovarian cancer cells. EdU assay and colony formation assay was used to test cell proliferation. Flow cytometry analysis and TUNEL assay were conducted to investigate cell apoptosis. Wound healing assay and transwell invasion assay assessed cell migration and invasion. DSCR8 was significantly up-regulated in ovarian cancer cells. Inhibited DSCR8 could suppress the progression of ovarian cancer. Also, YY1 could activate the expression of DSCR8 in ovarian cancer cells. Meanwhile, DSCR8/miR-3192-5p/YY1 axis was identified in ovarian cancer cells. MiR-3192-5p could function as tumor suppresser in ovarian cancer cells. Furthermore, DSCR8 and YY1 (Yin Yang 1) transcription factor could play the regulatory network in ovarian cancer cells. In a word, YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.
卵巢癌危及全球女性的生命。大量的长链非编码 RNA 已被发现可调节卵巢癌的进展。同时,lncRNA DSCR8(唐氏综合征关键区域 8)已被报道为肝癌中的癌基因。在这项研究中,我们旨在研究 DSCR8 在卵巢癌中的功能。qRT-PCR 分析评估了卵巢癌细胞中 DSCR8 的表达。EdU 测定和集落形成测定用于测试细胞增殖。流式细胞术分析和 TUNEL 测定用于研究细胞凋亡。划痕愈合测定和 Transwell 侵袭测定用于评估细胞迁移和侵袭。DSCR8 在卵巢癌细胞中显著上调。抑制 DSCR8 可抑制卵巢癌的进展。此外,YY1 可激活卵巢癌细胞中 DSCR8 的表达。同时,在卵巢癌细胞中鉴定出 DSCR8/miR-3192-5p/YY1 轴。miR-3192-5p 在卵巢癌细胞中可作为肿瘤抑制因子发挥作用。此外,DSCR8 和 YY1(阴阳 1)转录因子可在卵巢癌细胞中发挥调节网络作用。总之,YY1 诱导的 lncRNA DSCR8 通过 miR-3192-5p/YY1 轴促进卵巢癌的进展。